Evidence map›Paper›PMID 38578432›Full record

ArticleAngewandte Chemie (International ed. in English)2024

Magnetic Silica-Coated Fluorescent Microspheres (MagSiGlow) for Simultaneous Detection of Tumor-Associated Proteins.

Elias A Halabi, Isabel Gessner, Katherine S Yang, Jae-Jun Kim, Rupsa Jana, Hannah M Peterson, Joshua D Spitzberg, Ralph Weissleder

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elias A HalabiCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0003-1910-8196
Isabel GessnerCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0001-9674-161X
Katherine S YangCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0003-0182-950X
Jae-Jun KimCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0003-0722-3402
Rupsa JanaCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0009-0007-8368-9606
Hannah M PetersonCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0002-4716-2715
Joshua D SpitzbergCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0002-7937-9273
Ralph WeisslederCenter for Systems Biology Massachusetts General Hospital, Harvard Medial School, 185 Cambridge Street, CPZN 5206, 02114, Boston, MA, USA.ORCID 0000-0003-0828-4143

Funding

Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
FAST-FNA immune cell profiling in HNSCCR01CA257623 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FAQUIN, WILLIAM CLAY, WEISSLEDER, MD, PHD, RALPH · 2021 to 2025
$3.3M
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapyR01CA281735 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI RALPH WEISSLEDER, MD, PhD · 2023 to 2026
$2.3M
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)R01CA237332 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2020 to 2024
$1.9M
Bioorthogonal probe development for highly parallel in vivo imagingR33CA277820 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2023 to 2025
$1.2M
German Research Foundation 444077706National Science Foundation SNSF, P500PN_210730NCI NIH HHS R01 CA237332NCI NIH HHS R01CA237332NCI NIH HHS R01 CA257623NCI NIH HHS R01CA257623NCI NIH HHS R01 CA281735NCI NIH HHS R01CA281735NCI NIH HHS R33 CA277820NCI NIH HHS R33CA277820NCI NIH HHS T32 CA079443NCI NIH HHS T32CA079443
6 · The paper itself

Abstract

Multiplexed bead assays for solution-phase biosensing often encounter cross-over reactions during signal amplification steps, leading to unwanted false positive and high background signals. Current solutions involve complex custom-designed and costly equipment, limiting their application in simple laboratory setup. In this study, we introduce a straightforward protocol to adapt a multiplexed single-bead assay to standard fluorescence imaging plates, enabling the simultaneous analysis of thousands of reactions per plate. This approach focuses on the design and synthesis of bright fluorescent and magnetic microspheres (MagSiGlow) with multiple fluorescent wavelengths serving as unique detection markers. The imaging-based, single-bead assay, combined with a scripted algorithm, allows the detection, segmentation, and co-localization on average of 7500 microspheres per field of view across five imaging channels in less than one second. We demonstrate the effectiveness of this method with remarkable sensitivity at low protein detection limits (100 pg/mL). This technique showed over 85 % reduction in signal cross-over to the solution-based method after the concurrent detection of tumor-associated protein biomarkers. This approach holds the promise of substantially enhancing high throughput biosensing for multiple targets, seamlessly integrating with rapid image analysis algorithms.

Indexed as

Fluorescent DyesMicrospheresSilicon DioxideBiosensing TechniquesHumansNeoplasm ProteinsFluorescent DyesNeoplasm ProteinsSilicon DioxidebioconjugationELISAMagnetofluorescencemicroarraymultiplexing

Identifiers

PMID38578432
PMCPMC11998990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.